Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (4609)	10/21/2000 9:28:06 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 10280

No conspiracy (IMO) but ... if SEPR heard for the first time about the QTc issue on Wednesday night after the market closed - would they be able to say definitively on Thursday morning that they would not develop R-fluoxetine? It seems to me such a decision would take some careful thought. So I suspect that they knew of the issue (QTc) even if they heard for the first time Wednesday that LLY would drop the product. Thus, they undertook the examination at the same time that LLY did and once they knew LLY would not develop (Wednesday night) they were ready to announce they were proceeding with R-DDMS and dropping R-fluoxetine. ij